- Home
- / REYON Pharmaceutical
REYON Pharmaceutical
Stock Price
₩16.3 K
2024-10-29
Market Capitalization
₩301 B
2024-10-29
Revenue
₩145.9 B
FY, 2025
REYON Pharmaceutical Summary
Company Summary
- Overview
- REYON Pharmaceutical (이연제약) is a company that manufactures and distributes medicines. It provides eye drops, injections, antibiotics, skeletal muscle relaxants, coagulation drugs, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1955
- HQ
- Seoul, KR | view all locations
- Cybersecurity rating
Table of Contents
Key People
Yonghwan Yoo, Representative Director and President
LocationsView all
3 locations detected
Seoul, Seoul HQ
Korea (Republic of)
12F, Building A, Mirae Asset Tower, 620 Teheran-ro, Gangnam-gu
Seoul
Korea (Republic of)
8f, 416 Yeongdong-daero, Gangnam-gu
Jincheon, Chungcheongbuk-do
Korea (Republic of)
69-10 Hansam-ro, Deoksan-myeon
REYON Pharmaceutical Financials
Summary Financials
- Revenue (FY, 2025)
- ₩145.9B
- Gross profit (FY, 2025)
- ₩40.8B
- Net income (FY, 2025)
- (₩29.6B)
- Cash (FY, 2025)
- ₩6.7B
- EBIT (FY, 2025)
- (₩27.4B)
- Enterprise value
- $508.8B